版本:
中国

BRIEF-Acceleron Pharma qtrly loss per share $0.66

May 8 Acceleron Pharma Inc

* Acceleron pharma reports first quarter 2017 operational and financial results

* Acceleron pharma inc - collaboration revenue for q1 was $3.7 million

* Acceleron pharma inc qtrly loss per share $0.66

* Acceleron pharma inc - plans to initiate luspatercept phase 3 trial in first-line, lower-risk mds in early 2018 Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐